Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Non-invasive Intervention for Apnea of Prematurity
Neuromodulation of Limb Proprioceptive Afferents Using a Vibratory Device to Decrease Apnea, Intermittent Hypoxia and Bradycardia of Prematurity.
Status: Enrolling
Updated:  3/17/2016
Santa Monica UCLA Mecial Center
1984
mi
from 43215
Santa Monica, CA
Non-invasive Intervention for Apnea of Prematurity
Neuromodulation of Limb Proprioceptive Afferents Using a Vibratory Device to Decrease Apnea, Intermittent Hypoxia and Bradycardia of Prematurity.
Status: Enrolling
Updated: 3/17/2016
Santa Monica UCLA Mecial Center
1984
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
1968
mi
from 43215
Huntington Beach, CA
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
1968
mi
from 43215
Huntington Beach, CA
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
761
mi
from 43215
DeLand, FL
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
761
mi
from 43215
DeLand, FL
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
797
mi
from 43215
Orlando, FL
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
797
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
1749
mi
from 43215
Coeur d'Alene, ID
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
1749
mi
from 43215
Coeur d'Alene, ID
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
833
mi
from 43215
Sunset, LA
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
833
mi
from 43215
Sunset, LA
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
407
mi
from 43215
St. Charles, MO
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
407
mi
from 43215
St. Charles, MO
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
348
mi
from 43215
Charlotte, NC
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
346
mi
from 43215
Gaffney, SC
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
346
mi
from 43215
Gaffney, SC
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
353
mi
from 43215
Greenville, SC
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
353
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
365
mi
from 43215
Rock Hill, SC
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
365
mi
from 43215
Rock Hill, SC
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
349
mi
from 43215
Spartanburg, SC
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
349
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
404
mi
from 43215
Newport News, VA
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
404
mi
from 43215
Newport News, VA
Click here to add this to my saved trials
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated:  3/17/2016
GSK Investigational Site
400
mi
from 43215
Kralupy nad Vltavou,
Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2
Status: Enrolling
Updated: 3/17/2016
GSK Investigational Site
400
mi
from 43215
Kralupy nad Vltavou,
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of California
2109
mi
from 43215
San Francisco, CA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of California
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of Colorado Health Sciences Center
1159
mi
from 43215
Denver, CO
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of Colorado Health Sciences Center
1159
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of Chicago
270
mi
from 43215
Chicago, IL
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of Chicago
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Louisiana State University
797
mi
from 43215
New Orleans, LA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Louisiana State University
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of Maryland
343
mi
from 43215
Baltimore, MD
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Baystate Medical Center
563
mi
from 43215
Springfield, MA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Baystate Medical Center
563
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Mayo Foundation
559
mi
from 43215
Rochester, MN
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Mayo Foundation
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Duke University
352
mi
from 43215
Durham, NC
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Duke University
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Wake Forest University
306
mi
from 43215
Winston-Salem, NC
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Wake Forest University
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Vanderbilt University
331
mi
from 43215
Nashville, TN
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Vanderbilt University
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of Texas
1138
mi
from 43215
San Antonio, TX
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of Texas
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Latter Day Saints Hospital
1513
mi
from 43215
Salt Lake City, UT
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Latter Day Saints Hospital
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of Virginia
275
mi
from 43215
Charlottesville, VA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of Virginia
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
Univ of Washington
2006
mi
from 43215
Seattle, WA
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
Univ of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated:  3/22/2016
University of British Columbia
2051
mi
from 43215
Vancouver,
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)
Status: Enrolling
Updated: 3/22/2016
University of British Columbia
2051
mi
from 43215
Vancouver,
Click here to add this to my saved trials
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Status: Enrolling
Updated:  3/23/2016
National Jewish Health
1160
mi
from 43215
Denver, CO
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
Status: Enrolling
Updated: 3/23/2016
National Jewish Health
1160
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Status: Enrolling
Updated:  3/23/2016
University of Miami
992
mi
from 43215
Miami, FL
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Status: Enrolling
Updated: 3/23/2016
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
The Use of Lung Ultrasound to Diagnose RDS vs. TTN in Neonates Greater Than or Equal to 28 Weeks Gestation
Status: Enrolling
Updated:  3/24/2016
Icahn School of Medicine at Mount Sinai
mi
from 43215
New York, NY
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
The Use of Lung Ultrasound to Diagnose RDS vs. TTN in Neonates Greater Than or Equal to 28 Weeks Gestation
Status: Enrolling
Updated: 3/24/2016
Icahn School of Medicine at Mount Sinai
mi
from 43215
New York, NY
Click here to add this to my saved trials
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury
Status: Enrolling
Updated:  3/28/2016
Boston Med Ctr
642
mi
from 43215
Boston, MA
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury (ALI)
Assessing Respiratory Variability During Mechanical Ventilation in Acute Lung Injury
Status: Enrolling
Updated: 3/28/2016
Boston Med Ctr
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Alta Bates Summit Medical Center
2099
mi
from 43215
Oakland, CA
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Alta Bates Summit Medical Center
2099
mi
from 43215
Oakland, CA
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Indiana University Health/Riley Hospital for Children
166
mi
from 43215
Indianapolis, IN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Indiana University Health/Riley Hospital for Children
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Washington Universitiy
394
mi
from 43215
St Louis, MO
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Washington Universitiy
394
mi
from 43215
St Louis, MO
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University at Buffalo
299
mi
from 43215
Buffalo, NY
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University at Buffalo
299
mi
from 43215
Buffalo, NY
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
University of Rochester
354
mi
from 43215
Rochester, NY
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
University of Rochester
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Cincinnati University Hospital
98
mi
from 43215
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Cincinnati University Hospital
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Good Samaritan Hospital
98
mi
from 43215
Cincinnati, OH
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Good Samaritan Hospital
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated:  3/28/2016
Jackson Madison County General Hospital
431
mi
from 43215
Jackson, TN
Prematurity and Respiratory Outcomes Program (PROP)
Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol
Status: Enrolling
Updated: 3/28/2016
Jackson Madison County General Hospital
431
mi
from 43215
Jackson, TN
Click here to add this to my saved trials